CLINICAL_TRIALS
research
· 2014-01-31
Clinical Trial Update: Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC
Summary
An update on a trial evaluating whether pretreatment MRI can predict outcomes after radio-frequency ablation in hepatocellular carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN